Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6555481 | Pathology | 2018 | 5 Pages |
Abstract
Despite the reported elimination of measles virus in Australia, importation of cases from endemic countries continues to lead to secondary local transmission and outbreaks. Rapid laboratory confirmation of measles is paramount for individual patient management and outbreak responses. Further, it is important to rapidly distinguish infection from wild-type virus or vaccine strains to guide public health responses. We developed a high throughput, TaqMan-based multiplex reverse-transcription-polymerase chain reaction (PCR) assay using the BD MAX platform (Becton Dickinson) that simultaneously detects measles virus and differentiates between wild-type and vaccine strains without the need for sequencing.
Related Topics
Health Sciences
Medicine and Dentistry
Forensic Medicine
Authors
Kiran Thapa, Justin A. Ellem, Kerri Basile, Ian Carter, Tom Olma, Sharon C.-A. Chen, Dominic E. Dwyer, Jen Kok,